Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for two primary indications: type 2 diabetes management and chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
New oral medications could soon change how patients approach medical weight loss, offering an alternative to injectable treatments that have become increasingly common in recent years
They are not intended for human or veterinary use, diagnosis, treatment, cure, or prevention of any disease
However, competitive athletes must navigate anti-doping regulations
US$ 27.82
US$ 25.06
US$ 26.82
